| Vistusertib studied in …STUDIED_INderived29 of 29show fewer |
|---|
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · 29 trials list this drug (6 active) | — | — | Breast Carcinoma,Primary Peritoneal Carcinoma,Ovarian Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02813135Phase 1/Phase 2 · recruiting European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors · 29 trials list this drug (6 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02664935Phase 2 · completed National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer · 29 trials list this drug (6 active) | — | — | Adenocarcinoma,Squamous Cell Carcinoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01597388Phase 1 · completed AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer · 29 trials list this drug (6 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02546661Phase 1 · active not recruiting Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03334617Phase 2 · active not recruiting Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy · 29 trials list this drug (6 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299999Phase 2 · active not recruiting SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer · 29 trials list this drug (6 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02398747Phase 1 · completed Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02216786Phase 2 · completed A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02599714Phase 1 · completed Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer · 29 trials list this drug (6 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02730923Phase 1/Phase 2 · unknown Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) · 29 trials list this drug (6 active) | — | — | Carcinoma,Endometrial Carcinoma,Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02117167Phase 2 · completed SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03366103Phase 1/Phase 2 · terminated Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors · 29 trials list this drug (6 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02619864Phase 1 · completed mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme · 29 trials list this drug (6 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03071874Phase 2 · active not recruiting Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas · 29 trials list this drug (6 active) | — | — | Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831257Phase 2 · completed AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas · 29 trials list this drug (6 active) | — | — | Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03205046Phase 1/Phase 2 · terminated A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies · 29 trials list this drug (6 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02752204Phase 2 · completed An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma · 29 trials list this drug (6 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02583542Phase 1/Phase 2 · unknown A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers · 29 trials list this drug (6 active) | — | — | Lung Squamous Cell Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02064608Phase 1 · completed Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer · 29 trials list this drug (6 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03061708Phase 2 · terminated Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy · 29 trials list this drug (6 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03082833Phase 2 · terminated Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy · 29 trials list this drug (6 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03166176Phase 2 · withdrawn Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy · 29 trials list this drug (6 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03166904Phase 2 · withdrawn Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy · 29 trials list this drug (6 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02640755Phase 1 · completed Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03106155Phase 2 · terminated Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification · 29 trials list this drug (6 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02780830Phase 1 · withdrawn AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026402Phase 1 · completed Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014 · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01793636Phase 2 · terminated A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer · 29 trials list this drug (6 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |